Cargando…

IQOS: examination of Philip Morris International’s claim of reduced exposure

BACKGROUND: New electronic heated tobacco products are being introduced in the global market and are gaining popularity. In 2016, Philip Morris International, Inc. (PMI) submitted a modified risk tobacco product (MRTP) application to the Food and Drug Administration (FDA) to market IQOS in the USA w...

Descripción completa

Detalles Bibliográficos
Autores principales:	St.Helen, Gideon, Jacob III, Peyton, Nardone, Natalie, Benowitz, Neal L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252487/ https://www.ncbi.nlm.nih.gov/pubmed/30158205 http://dx.doi.org/10.1136/tobaccocontrol-2018-054321

Ejemplares similares

IQOS debut in the USA: Philip Morris International’s heated tobacco device introduced in Atlanta, Georgia
por: Churchill, Victoria, et al.
Publicado: (2020)

Modelling the impact of a new tobacco product: review of Philip Morris International’s Population Health Impact Model as applied to the IQOS heated tobacco product
por: Max, Wendy B, et al.
Publicado: (2018)

Twenty‐Four‐Hour Cardiovascular Effects of Electronic Cigarettes Compared With Cigarette Smoking in Dual Users
por: Benowitz, Neal L., et al.
Publicado: (2020)

Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020
por: Sponsiello-Wang, Zheng, et al.
Publicado: (2019)

Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents
por: Elias, Jesse, et al.
Publicado: (2018)

Philip Morris ejected from Canadian vaccine collaboration
por: Kirby, Tony
Publicado: (2023)

Minor Tobacco Alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New Analytical Methods
por: Jacob, Peyton, et al.
Publicado: (2022)

Philip Morris involvement in the development of an air quality laboratory in El Salvador
por: Kummerfeldt, C E, et al.
Publicado: (2009)

Philip Morris International’s Formula 1 Sponsorship-Linked Marketing: Transformation From Marlboro to Mission Winnow
por: Dewhirst, Timothy, et al.
Publicado: (2023)

Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers
por: St.Helen, Gideon, et al.
Publicado: (2019)

Uncovering Philip Morris International’s Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame
por: Charoenca, Naowarut, et al.
Publicado: (2021)

Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations
por: Velicer, Clayton, et al.
Publicado: (2015)

Revolution or redux? Assessing IQOS through a precursor product
por: Elias, Jesse, et al.
Publicado: (2018)

“A Good Personal Scientific Relationship”: Philip Morris Scientists and the Chulabhorn Research Institute, Bangkok
por: MacKenzie, Ross, et al.
Publicado: (2008)

The Toxic Effects of Cigarette Additives. Philip Morris' Project Mix Reconsidered: An Analysis of Documents Released through Litigation
por: Wertz, Marcia S., et al.
Publicado: (2011)

United States Food and Drug Administration’s authorization of reduced exposure claims for IQOS(®): implications for regulation in Latin America
por: Eckford, Robert, et al.
Publicado: (2022)

IQOS campaign in Israel
por: Rosen, Laura J, et al.
Publicado: (2018)

Possible hepatotoxicity of IQOS
por: Chun, Lauren, et al.
Publicado: (2018)

Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke
por: Nabavizadeh, Pooneh, et al.
Publicado: (2018)

Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non-Smokers
por: Dempsey, Delia A., et al.
Publicado: (2013)

IQOS labelling will mislead consumers
por: McKelvey, Karma, et al.
Publicado: (2018)

Heated tobacco products: the example of IQOS
por: Glantz, Stanton A
Publicado: (2018)

Categorizing IQOS-Related Twitter Discussions
por: Barker, Joshua O., et al.
Publicado: (2021)

Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland
por: Hair, Elizabeth C, et al.
Publicado: (2018)

Factors that influence smokers’ and ex-smokers’ use of IQOS: a qualitative study of IQOS users and ex-users in the UK
por: Tompkins, Charlotte N E, et al.
Publicado: (2021)

Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA
por: Henderson, Katherine C, et al.
Publicado: (2023)

William Morris
por: De Carlo, Giancarlo, 1919-2005
Publicado: (1955)

Morris Fishbein
por: Spiro, Howard M.
Publicado: (1970)

Thomas Morris
Publicado: (1888)

James Morris
Publicado: (1910)

Noah Morris
Publicado: (1947)

Prof. Philip H. Austen
por: Tucker, Elisha G., et al.
Publicado: (1879)

Philip Johnson
por: Jacobus, John M.
Publicado: (1962)

Philip of Spain /
por: Kamen, Henry
Publicado: (1997)

Philips Symposium
Publicado: (1987)

Anticipating IQOS market expansion in the United States
por: Abroms, Lorien, et al.
Publicado: (2022)

Potential Harm of IQOS Smoke to Rat Liver
por: Granata, Silvia, et al.
Publicado: (2023)

“It doesn’t seem to make sense for a company that sells cigarettes to help smokers stop using them”: A case study of Philip Morris’s involvement in smoking cessation
por: McDaniel, Patricia A., et al.
Publicado: (2017)

“Where There’s Smoke, There’s Fire”: A Content Analysis of Print and Web-Based News Media Reporting of the Philip Morris–Funded Foundation for a Smoke-Free World
por: Watts, Christina, et al.
Publicado: (2019)

Sociology. /Ginsberg, Morris,
por: Ginsberg, Morris 1889-
Publicado: (1955)

Cannot write session to /tmp/vufind_sessions/sess_cvrk3ikrkq46fskt9iotugb35m